Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors.

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

1998 • 820 citations

Preparation and Properties of Partially Purified Cytochrome P-450 and Reduced Nicotinamide Adenine Dinucleotide Phosphate-Cytochrome P-450 Reductase from Rabbit Liver Microsomes

1974 • 518 citations

Evaluation of Atypical Cytochrome P450 Kinetics with Two-Substrate Models: Evidence That Multiple Substrates Can Simultaneously Bind to Cytochrome P450 Active Sites

1998 • 508 citations

Generating Optimal Linear PLS Estimations (GOLPE): An Advanced Chemometric Tool for Handling 3D‐QSAR Problems

1993 • 359 citations

Cytochrome P450TB (CYP2C): A major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liver

1993 • 258 citations

Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms.

1997 • 208 citations

Speculations on the Substrate Structure-Activity Relationship (SSAR) of cytochrome P450 enzymes

1992 • 203 citations

Tolbutamide hydroxylation by human liver microsomes

1988 • 198 citations

QSAR and 3D QSAR in drug design Part 2: applications and problems

1997 • 173 citations

Properties of cytochrome P450 isoenzymes and their substrates part 2: properties of cytochrome P450 substrates

1997 • 113 citations

The Substrate Binding Site of Human Liver Cytochrome P450 2C9: An Approach Using Designed Tienilic Acid Derivatives and Molecular Modeling

1995 • 111 citations

In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A

1996 • 103 citations

Properties of cytochrome P450 isoenzymes and their substrates Part 1: active site characteristics

1997 • 89 citations

Three-dimensional quantitative structure-activity relationship for inhibitors of cytochrome P4502C9.

1996 • 87 citations

Enzymatic Determinants of the Substrate Specificity of CYP2C9: Role of B‘−C Loop Residues in Providing the π-Stacking Anchor Site for Warfarin Binding

1999 • 83 citations

Autoactivation and activation of the cytochrome P450s.

1998 • 72 citations

Ticlopidine inhibition of phenytoin metabolism mediated by potent inhibition of CYP2C19*

1997 • 71 citations

Involvement of multiple cytochrome P450 isoforms in naproxen O-demethylation

1997 • 64 citations

Molecular modelling of human CYP2C subfamily enzymes CYP2C9 and CYP2C19: rationalization of substrate specificity and site-directed mutagenesis experiments in the CYP2C subfamily

1998 • 59 citations

Effect of fluoxetine, norfluoxetine, sertraline and desmethyl sertraline on human CYP3A catalyzed 1'-hydroxy midazolam formation in vitro.

1995 • 55 citations

Identification of Residues 286 and 289 as Critical for Conferring Substrate Specificity of Human CYP2C9 for Diclofenac and Ibuprofen

1998 • 50 citations

Relationships between the levels of cytochrome P4502C9 and its prototypic catalytic activities in human liver microsomes.

1994 • 45 citations

Ipriflavone as an inhibitor of human cytochrome P450 enzymes

1998 • 32 citations

Pharmacological activity and membrane interactions of antiarrhythmics: 4D-QSAR/QSPR analysis.

1998 • 27 citations

Warfarin Analog Inhibition of Human CYP2C9-Catalyzed S-Warfarin 7-Hydroxylation

1997 • 17 citations

Structure and Function of Cytochrome P-450

1986 • 6 citations